Structural divergence among cannabinoids influences membrane dynamics: A 2H Solid-State NMR analysis  by Tiburu, Elvis K. et al.
1768 (2007) 2049–2059
www.elsevier.com/locate/bbamemBiochimica et Biophysica ActaStructural divergence among cannabinoids influences membrane
dynamics: A 2H Solid-State NMR analysis
Elvis K. Tiburu a, Caroline E. Bass a, Jochem O. Struppe b, Gary A. Lorigan c,
Shalom Avraham a, Hava Karsenty Avraham a,⁎
a Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA
b NMR Division, Bruker-Biospin Corporation, Billerica, MA 01821, USA
c Department of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA
Received 21 October 2006; received in revised form 14 April 2007; accepted 24 April 2007
Available online 5 May 2007Abstract
Cannabinoids are compounds that can modulate neuronal functions and immune responses via their activity at the CB1 receptor. We used
2H
NMR order parameters and relaxation rate determination to delineate the behavior of magnetically aligned phospholipid bilayers in the presence of
several structurally distinct cannabinoid ligands. THC (Δ9-Tetrahydrocannabinol) and WIN-55,212-2 were found to lower the phase transition
temperature of the DMPC and to destabilize their acyl chains leading to a lower average SCD (≈0.13), while methanandamide and CP-55,940
exhibited unusual properties within the lipid bilayer resulting in a greater average SCD (≈0.14) at the top of the phospholipid upper chain. The
CB1 antagonist AM281 had average SCD values that were higher than the pure DMPC lipids, indicating a stabilization of the lipid bilayer. R1Z
versus |SCD|
2 plots indicated that the membrane fluidity is increased in the presence of THC and WIN-55,212-2. The interaction of CP-55,940 with
a variety of zwitterionic and charged membranes was also assessed. The unusual effect of CP-55,940 was present only in bicelles composed of
DMPC. These studies strongly suggest that cannabinoid action on the membrane depends upon membrane composition as well as the structure of
the cannabinoid ligands.
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Exogenous and endogenous cannabinoids bind to and activate
the cannabinoid receptors CB1 and CB2 [1–4]. These ligands are
important signaling molecules in the central nervous system
(CNS) and also regulate certain immune responses [5–8]. The
CB1 receptor is found predominantly within the CNS and
mediates many of the central effects of marijuana including
memory impairment and analgesia [9,10], while the CB2 receptor
is found predominantly in the periphery most notably on immune
cells [4,11]. Cannabinoid receptors are members of the G-protein
coupled receptors (GPCR), coupled to Gi/o proteins, which are
linked to several signal transduction events including inhibition of
adenylyl cyclase, modulation of ion channels and activation of
mitogen-activated protein (MAP) kinase [12–15]. Four distinct
classes of cannabinoid agonists have been identified based upon
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cannabinoids are dibenzopyran derivatives based upon the
structure of Δ9-tetrahydrocannabinol (THC), which is the major
psychoactive constituent of marijuana. The non-classical canna-
binoids are synthetic bicyclic and tricyclic analogs of THC that
lack a central pyran ring and include the compound CP-55,940.
WIN-55,212-2 is the prototypical aminoalkylindole, a group
whose structure varies greatly from the classical and non-classical
cannabinoids. With this structural divergence, there is evidence to
suggest that WIN-55,212-2 binds to the CB1 receptor in a
different manner than other cannabinoid agonists [19,20].Fig. 1. The structures of the cannabinoid ligands used for these studies. The m
methanandamide, (3) CP-55,940, (4) Δ9-THC and (5) WIN-55,212-2.Anandamide and 2-Arachidonoyl-sn-glycero-3-phosphate (2-
AG) are endogenous ligands, members of the eicosanoid class
of cannabinoids, which are arachidonic acid derivatives and are
structurally different from other cannabinoid classes. In addition,
several cannabinoid antagonists based on a diarylpyrazole
structure have been characterized including SR-141716A and
AM281 [21,22]. Some of the antagonists also act as inverse
agonists, which produce pharmacological effects opposite of
cannabinoid agonists [20,23].
Cannabinoids are being explored as pharmaceutical targets
with potential applications in the treatment of neurologicalolecular structures of five prototypical cannabinoid ligands. (1) AM281, (2)
Fig. 2. 2H NMR spectra of cannabinoid ligands incorporated into bicelle
samples. 2H NMR spectra of BicPC studied from 25 °C to 40 °C with 5 °C
increment intervals in the presence of 2 mol% cannabinoid. (A) Pure BicPC, (B)
methanandamide/BicPC, and (C) the stack at 35 °C of pure BicPC superimposed
on BicPC in the presence of cannabinoids.
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functional relevance of the cannabinoid system emerges, the
need to determine the structural requirements for cannabinoid
pharmacological activity becomes imperative. Prior to the
discovery of specific binding sites for cannabinoids, the
majority of THC's effects were thought to be mediated by its
ability to disrupt biological membranes [24–26]. Indeed, many
of the cannabinoids are highly lipophilic and difficult to
dissolve in aqueous solution, a property that limits their clinical
usefulness. Despite this well-known characteristic of cannabi-
noids, the mechanisms by which cannabinoids interact with the
lipid bilayer have not been investigated in depth.
The current theory of receptor ligand interaction proposes
that ligands accumulate in the lipid bilayer and undergo a
process of lateral diffusion to interact with integral receptors
[27]. Cannabinoids are amphipathic compounds whose activity
may be governed in part by their alignment and orientation
within the lipid bilayer. Given the structural diversity of
cannabinoids, their ability to interact with the lipid bilayer may
determine their relative efficacy as well as their location in
reference to the binding site on the receptor. In order to better
understand the requirements for efficacy among the cannabi-
noid ligands, we have examined the biophysical properties of
prototypical cannabinoids at the lipid bilayer using solid-state
NMR spectroscopy, focusing on how cannabinoids affect the
stability and fluidity of the phospholipid membrane. Under-
standing the mechanism by which the cannabinoid ligands
interact with the lipid bilayer should further define the
pharmacophores necessary for cannabinoid activity and aid in
the development of highly efficacious cannabinoid ligands.
In this study, the ligands were incorporated into both
zwitterionic and charged magnetically aligned phospholipid
bilayers (bicelles) and the dynamic properties were probed
using solid-state NMR spectroscopy. Bicelles were developed
to mimic the properties of biological membranes. These bicelles
are formed when a long-chain phospholipid, 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC) is mixed with a short-
chain detergent such as 1,2-dihexanoyl-sn-glycero-3-phospho-
choline (DHPC) [28,29]. The bicelles are spontaneously aligned
with their bilayer normal perpendicular to the static magnetic
field due to their negative magnetic susceptibility anisotropy
(Δχb0). Doping of zwitterionic bicelles with paramagnetic
lanthanide ions possessing large positive magnetic susceptibil-
ities (Eu3+, Er3+, Tm3+, and Yb3+) can cause the bicelles to flip
90°, where the average bilayer normal is colinear with the
direction of the static magnetic field [30]. The structure of
magnetically aligned bicelles depends on the molar ratio of
DMPC to DHPC. The DMPC/DHPC bicelle model membrane
system was selected for this study because it has been well
characterized by solid-state NMR spectroscopy [29,31–36].
There are currently no reports where all five structural
classes of cannabinoid ligands have been studied in magneti-
cally aligned phospholipid bilayers. Furthermore, to our
knowledge, no one has studied the biophysical properties of a
cannabinoid ligand in charged phospholipid bilayers. The
chemical features of the cannabinoid ligands suggest that
some of their biological effects could be related to their physicalinteractions with membranes possessing different lipid compo-
sitions. Thus, this is the first report to examine the dynamics and
relaxation parameters of prototypical cannabinoids from each
structural class incorporated into zwitterionic and charged
magnetically aligned phospholipid bilayers.
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2.1. Materials
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-
glycero-3-phospho-ethanolamine (DMPE), 1,2-dimyristoyl-sn-glycero-3-[Phos-
pho-L-serine] (DMPS), 1,2-dimyristoyl-sn-glycero-3-[Phospho-rac(1-glycerol)]
(DMPG), 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) and DMPC-d54
were purchased from Avanti Polar Lipids (Alabaster, AL). All phospholipids were
dissolved in chloroform and stored at −20 °C prior to use. THC, methanandamide
and CP-55,940 were purchased from Sigma-Aldrich (St. Louis, MO). WIN-
55,212-2 and AM281 were purchased from Tocris (Ellisville, MO). All ligands
were dissolved in DMSO and stored at 4 °C prior to use. HEPES (N-[2-
hydroxyethyl]piperazine-N′-2-ethanesulfonic acid) was obtained from Sigma-
Aldrich. Deuterium-depleted water was obtained from Isotec (Miamisburg, OH).
2.2. Sample preparation
The standard DMPC/DHPC (BicPC) bicelle sample, consisting of 25% (w/w)
phospholipid to solution (with a q=3.5), was made in a 25-mL pear-shaped flask.Fig. 3. Orientation order parameter profiles calculated at 35 °C for cannabinoid ligand
the presence of 2 mol% cannabinoids and DMPC/DHPC lipid bilayers prepared in
BicPC, (C) THC/BicPC and (D) WIN-55,212-2/BicPC. The SCD was calculated fro
35 °C. The SCD was calculated starting from the methyl deuteron at the end of the
uncertainties in the measurements for panels A–D are approximately±0.002, 0.001In the cannabinoid bicelle samples, up to 8 mol% of the cannabinoid ligand was
addedwith respect to DMPC, depending on themembrane stability. Themixture in
the flask was rotovaped down to remove the chloroform/DMSO mixture from the
phospholipid/cannabinoid mixture, and then the flask was placed under high
vacuum conditions overnight. The charged bicelles were prepared by replacing
DMPCwith 10 mol% of DMPE, DMPS or DMPG (to give a DMPC/charged lipid
molar ratio of 9:1). To ensure that all of the DMSO was removed during the
overnight storage, we prepared bicelle samples from lipids dissolved in chloroform
or a chloroform/DMSO mixture. The NMR spectra showed no changes in
alignment in the presence or absence of DMSO.
The following day, an appropriate amount of deuterium-depleted water was
added to the sample. The pH of all the samples was ∼5.5±0.1 [37]. The flask
was next vortexed briefly, sonicated with an FS30 (Fisher Scientific) bath
sonicator without heat. Several freeze–thaw cycles between liquid nitrogen and
room temperature made the dispersion more homogenous and also removed all
of the air bubbles. Typically, the total mass of the prepared bicelle sample was
300 mg. The AM281/BicPC mixture was slightly turbid, indicating non-
homogenous mixing. The sample was placed on ice for 1 h and then transferred
to a 21-mm NMR flat bottom tube with a 5-mm o.d. via a Pasteur pipette. To
monitor bicelle alignment with 2H NMR spectroscopy, a 20:1 mole ratio of
regular and chain deuterated phospholipids was used in this study.s incorporated into BicPC. Orientation order parameter (SCD) profile of BicPC in
the absence of the cannabinoids. (A) Methanandamide/BicPC, (B) CP-55,940/
m the quadrupolar splittings obtained from the magnetically aligned spectra at
acyl chain towards the methylene close to the upper chain of the DMPC. The
, 0.002 and 0.003, respectively, for triplicate data points.
Fig. 4. Order parameter profiles calculated at 35 °C for cannabinoid ligands incorporated into bicelles of different composition. Orientation order parameter (SCD)
profile of 4 mol% CP-55,940 incorporated into magnetically aligned phospholipid bilayers. (A) BicPC, (B) BicPE, (C) BicPG, and (D) BicPS. The SCD was calculated
from the quadrupolar splittings obtained from the magnetically aligned spectra at 35 °C. The SCD was calculated starting from the methyl deuteron at the end of the acyl
chain towards the methylene close to the upper chain of the phospholipid. The uncertainties in the measurements for panels A–D are approximately ±0.002, 0.001,
0.003 and 0.001, respectively, for triplicate data points.
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All solid-state NMR experiments were carried out on a modified Bruker
AVANCE wide bore 500/89 magnet configured to conduct high-power solid-
state NMR studies. The solid-state NMR spectra were gathered with a static
double-tuned 5 mm round-coil solid-state NMR probe from Bruker-Biospin,
Inc. 2H NMR spectra were recorded at 76.8 MHz using a standard quadrupole-
echo pulse sequence (3.0 μs 90° pulses, 45 μs interpulse delay, 5.12 ms
acquisition time, 0.4 s recycle delay, and a 150-kHz sweep width). Typically
20,000 scans were accumulated in the quadrature detection mode. An
exponential line broadening of 100 Hz was applied to the free induction
decay before Fourier transformation. The experiments were carried out in a
temperature range from 20 to 50 °C with 5 °C increments.
2.4. Order parameter calculations
Order parameters were calculated using the equation given by Prosser et al.
for the phospholipid bicelle system [33]:
SiCD ¼ Di1=Dip ð1Þ
where SCD
i is the order parameter for a deuteron attached to the ith carbon of the
acyl chains, Δl
i is the observed quadrupolar splittings for a deuteron attached toith carbon and Δp
i represents the splittings that would be observed for a
stationary deuteron in a CD bond pointing along the external magnetic field
[33]. We also used the integration method developed by Lafleur et al. to
delineate the resonance peaks that could not be resolved during the alignment
process [38]. Order parameters were calculated assuming a quadrupolar
coupling constant of e2qQ/h=168 kHz.
2.5. T1 relaxation measurement
Spin-lattice relaxation times (T1Z) were obtained by the inversion-recovery
technique with the pulse sequence 180°-T–90°-τ–90°-acquire, where T is a set
of variable delays used to determine T1Z [39]. The variable T delays used for the
T1Z measurements were fitted using the following exponential function:
IðtÞ ¼ Ið0Þ ½1 AexpðT=T1ZÞ ð2Þ
where I(t) is the change in peak intensity as a function of the variable T delay
(varied from 1 ms to 7 s) used to calculate T1Z, A is a fitting parameter and is
close to 2, and I(0) is 1 [40]. The 2H spin-lattice relaxation rate, R1Z, is related to
T1Z by R1Z=1/T1Z, and the standard deviation for each R1Z value is
approximately±0.002 ms.
2054 E.K. Tiburu et al. / Biochimica et Biophysica Acta 1768 (2007) 2049–20593. Results
The 2H NMR spectra corresponding to one of the structural
classes of cannabinoids interacting with magnetically aligned
DMPC/DHPC phospholipid bilayers are shown in Fig. 2. The
choice of the DMPC bicelles that pertinent information could be
obtained from high-resolution spectra. As shown in Fig. 2A, the
2H NMR spectra of the pure BicPC (DMPC/DHPC bicelle)
phospholipid bilayers, in the absence of cannabinoids, exhibited
a collection of symmetrical doublets characteristic of molecules
undergoing fast and symmetrical 2H motions above 30 °C.
These spectra were well aligned in the magnetic field at
temperatures of up to 45 °C, as previously demonstrated
[32,35,41]. When 2 mol% of methanandamide, a syntheticFig. 5. Order parameter profiles and relaxation rates calculated at 35 °C for
AM281 incorporated into bicelles. (A) Orientation order parameter (SCD) profile
of 2 mol% AM281 incorporated into magnetically aligned phospholipid bilayers
(BicPC). The SCD was calculated from the quadrupolar splittings obtained from
the magnetically aligned spectra at 35 °C. The SCD was calculated starting from
the methyl deuteron at the end of the acyl chain towards the methylene close to
the upper chain of the phospholipid. The uncertainty in the measurements is
approximately ±0.001 for triplicate data points. (B) 2H relaxation rate
measurements as a function of carbon position along the acyl chain for BicPC
in the presence of 2 mol% AM281 with respect to BicPC. The R1Z values were
calculated from the peak intensities as a function of variable T delay at 35 °C.
The uncertainties in the measurements for panels A and B are approximately
±0.001 and ±1.0 s−1, respectively, for triplicate data points.analogue of anandamide, was incorporated into the bicelles, we
observed a downward shift in the alignment temperature to
approximately 27 °C, indicating a change in the liquid-
crystalline phase transition temperature in the presence of
methanandamide (Fig. 2B). However, at higher temperatures
(40 °C), a sharp isotropic peak was observed which is
characteristic of a bicellar structure consisting of different
components (Fig. 2B). In contrast, the alignment temperature
was significantly lower (25 °C) upon incorporation of the non-
classical ligand, CP-55,940, into the bicelles and remained
stable up to 40 °C (Suppl. Fig. 1A).
The effects of THC on the aligned phospholipid bilayers
followed the trend in Fig. 2A, but the bilayers lost their
alignment at higher temperatures (Suppl. Fig. 1B). The spectral
properties of bicelles containing WIN-55,212-2 were identical
to the control bicelles except that the quadrupolar splittings
were significantly reduced in the presence of 2 mol% WIN-
55,212-2 (Suppl. Fig. 1C). Interestingly, the spectra of the
bicelles in the presence of the antagonist/inverse agonist
AM281 (Suppl. Fig. 1D) were similar to the CP-55,940 spectra
(Suppl. Fig. 1A), which showed well aligned bicelles from
25 °C to 35 °C, but no bicelle alignment above 35 °C. Of note,
the AM281 sample became turbid at temperature scans above
35 °C, suggesting that this ligand precipitates out of solution
under physiological temperatures. The 2H NMR spectra of the
bicelles, in the presence of cannabinoids, were stacked at 35 °C
(Fig. 2C). Moreover, the quadrupolar splittings were reduced
when the bicelles were exposed to the cannabinoid ligands,
although the 2H NMR spectra of the bicelles in the presence
of CP-55,940 were broader than that of the control sample
(Fig. 2C). All of the experiments were conducted using up to an
8 mol% concentration of ligands, but comparisons were made at
2 mol% since greater concentrations of Δ9-THC totally
disrupted the bilayer, preventing the collection of accurate
spectra.
The general profile of the smooth segmental C\D bond
order parameters (SCD) of the acyl chain in the presence of 2 mol
% cannabinoid ligands at 35 °C is shown in Fig. 3. The C\D
bond order parameters provide a means of determining the
motional restriction of the lipid acyl chains following
incorporation of the ligands into the bicelles, assuming that
the static quadrupolar interaction tensor for the C\D bond is
axially-symmetric. A characteristic profile of decreasing order
from the carboxyl group of the fatty acyl ester towards the
methyl group of the acyl chain was observed in the presence of
the ligands. The order parameter (SCD) of the pure BicPC of up
to ~0.14 at 35 °C is consistent with previous studies [33,42].
However, upon incorporation of methanandamide, the SCD
profile of the bicelles was lower than that of the pure BicPC
bicelles (Fig. 3A). The destabilization effect on the acyl chain in
the presence of 2 mol% methanandamide was least towards the
carboxyl group of the fatty acyl ester. Of note, the interaction of
CP-55,940 with the bicelle bilayer environment was unusual
(Fig. 3B), showing a characteristic profile of increasing order at
the carboxyl group of the fatty acyl ester, and a corresponding
decrease in order parameters towards the methyl group of the
acyl chain. The dual properties exhibited by the bicelles in the
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those of the DMPC interacting with 2 mol% CP-55,940
(Fig. 4A). Higher mol% concentrations of CP-55,940 produced
an even greater enhancement of ordering at the carboxyl group
of the fatty acyl ester, which was coupled with increased
disorder in the acyl chain (data not shown). The bicelles in the
presence of 2 mol% THC showed a progressive decrease in the
order parameters from the carboxyl group of the fatty acyl ester
to the acyl chain of the bicelles, indicating a disordering effect
of the ligand on the bilayer environment (Fig. 3C). Similar
profiles were recorded for the bicelles treated with 2 mol%
WIN-55,212-2, suggesting that both ligands interact with the
lipid bilayer in a similarly disruptive fashion (Fig. 3D).
The ability of CP-55,940 to affect the dynamics of a variety
of phospholipid bilayers was also examined (Fig. 4).
Intercalation of CP-55,940 molecules can change the
dynamics of the carboxyl group of the fatty acyl ester of the
zwitterionic phospholipid bilayers (BicPC) (Fig. 4A). How-
ever, when 4 mol% CP-55,940 was incorporated into BicPE, a
zwitterionic membrane with a smaller upper chain, the un-
usual properties of the cannabinoid ligand were lost (Fig. 4B).Fig. 6. 2H relaxation rates plotted as a function of carbon number at 35 °C. 2H relaxa
BicPC in the presence of 2 mol% cannabinoids and BicPC lipid bilayers prepared in
BicPC, (C) THC/BicPC, and (D) WIN-55,212-2/BicPC. The R1Z values were calcu
uncertainty in the measurements is approximately ±1.0 s−1 for triplicate data pointsFurthermore, at 4 mol% CP-55,940 in the presence of
negatively charged phospholipid bilayers (BicPG or BicPS),
the uptake of the cannabinoid ligand into the membrane
destabilized the bilayer from the carboxyl group of the fatty
acyl ester of the lipids to the end of the acyl chain, again
without the unusual properties shown in the zwitterionic
BicPC and BicPE (Fig. 4C and D).
When the BicPC/AM281 spectra were collected at 35 °C, the
profile of the smooth segmental C\D bond order parameters
(SCD) of the acyl chain showed modest differences (Fig. 5A)
when compared with the control sample. However, the bicelle
sample in the presence of 2 mol% AM281 was turbid at 35 °C,
indicating that AM281 was not soluble in the DMPC lipid
bilayer. Hence, accurate data could not be obtained with AM281
at this temperature and concentration. It is apparent that AM281
has a visible effect on membrane stability as evidenced by the
aligned spectra at 35 °C (Fig. 5A). At 2 mol% AM281, the SCD
profile was significantly higher at all points along the
phospholipid acyl chain compared to the pure BicPC, indicating
that AM281 stabilized the lipid bilayer both at the carboxyl
group of the fatty acyl ester and along the acyl chain.tion rate measurements as a function of carbon position along the acyl chain for
the absence of the cannabinoids. (A) Methanandamide/BicPC, (B) CP-55,940/
lated from the peak intensities as a function of variable T delay at 35 °C. The
.
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about molecular motions that occur on the time scale of the
inverse Lamor frequency or even less. To measure the
macroscopic relaxation rates of the BicPC system (which can
provide fast internal dynamic information) as a function of
variable T delay, 2H relaxation rates (R1Z) were determined for
the pure BicPC and for the bicelles in the presence of 2 mol% of
the cannabinoid ligands (Fig. 6). The general trend of the R1Z
profiles of these ligands followed the profiles of the smooth
order parameters, and the R1Z values increased in conjunction
with the carbon position along the acyl chains of the DMPC in
the studied systems (Fig. 6). The R1Z values for the pure BicPC
were superimposed over those for the bicelles in the presence of
the 2 mol% cannabinoid ligands, and these profiles compared
favorably to the order parameter profile displayed in Fig. 3. A
general trend of short R1Z values (from the carboxyl group of
the fatty acyl ester towards the acyl chain of the DMPC bilayers)
was observed for the bicelles in the presence of 2 mol%
methanandamide, and these values were then compared with
those for the pure BicPC (Fig. 6A), which showed longer R1Z
values. The R1Z profiles in the presence of the ligand taperedFig. 7. R1Z versus |SCD|
2 plots for the cannabinoid ligands incorporated into the bicelle
of cannabinoid ligands. (A) Methanandamide/BicPC, (B) CP-55,940/BicPC, (C) TH
plots of R1Z versus |SCD|
2 are a measure of bilayer fluidity, with steeper slopes indica
measurements of about ±7%.towards the carboxyl group of the fatty acyl ester to almost
convergence with the pure bicelle profile, suggesting slightly
unusual properties. In addition, the R1Z measurements in the
presence of CP-55,940 (Fig. 6B) displayed an unusual effect
that was proportional to the order parameter profiles (Fig. 3B).
Similarly, R1Z trends revealed shorter relaxation rates from the
upper chain towards the acyl chain in the presence of 2 mol%
concentrations of either THC or WIN-55,212-2, respectively
(Fig. 6C and D), without showing the unusual profiles of
methanandamide and CP-55,940. AM281 also caused the
BicPC to display R1Z profiles, indicating a decrease in mem-
brane fluidity following incorporation of 2 mol% AM281 into
the bicelles (Fig. 5B). These results support the SCD profile at
2 mol% AM281 (Fig. 5A).
Acyl chain methylene 2H NMR spin-lattice relaxation rates
have been shown to follow a square-law dependence on SCD.
The plots of the R1Z versus |SCD|
2 curves are a measure of
bilayer fluidity, with steeper slopes indicating greater fluidity
[26,43,44]. Such plots are therefore useful in distinguishing
between the types of motion that modulate relaxation processes
within the bilayer. As shown in Fig. 7, we plotted four graphss. Square-law dependence of R1Z versus |SCD|
2 for BicPC alone or in the presence
C/BicPC, and (D) WIN-55,212-2/BicPC. The overall slopes of the best linear fit
ting greater fluidity. The uncertainty in the data points is similar, with T1Z error
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BicPC superimposed on pure BicPC. The slopes from the
graphs are respectively 1058±12 s−1, 944±21 s−1, 1466±
17 s−1, 1571±18 s−1, and the pure BicPC has a slope of 1100±
15 s−1. THCBicPC and WINBicPC both have R1Z intercepts
close to the value of 2 as expected for a bilayer whose
relaxations are governed by whole bilayer motion. Taken
together, our data demonstrate the effects of cannabinoid
ligands on membrane dynamics and fluidity.
4. Discussion
In this study, we examined the perturbation effects of five
structurally distinct cannabinoid ligands incorporated into
magnetically aligned phospholipid bilayers. The first evidence
that cannabinoid ligands are incorporated into BicPC is shown
in Fig. 2, where control BicPC bicelles spontaneously align
close to their phase transition temperature of approximately
35 °C and remain stable at higher temperatures. At temperatures
below their phase transition, the bicelles do not display sharp
resonances characteristic of the fast limit spectra at higher
temperatures. However, a well aligned liquid-crystalline phase
was observed at lower temperatures in the bicelles in the
presence of cannabinoid ligands. The ability of the ligands to
decrease the phase transition is linked to a liquid-crystalline
phase (Lα-phase) in which the phospholipid chains are highly
flexible and undergo rapid axially-symmetric orientations.
These changes in bilayer properties cause dramatic alterations
in the molecular order and dynamics of the membrane. Our
results are in agreement with earlier 2H NMR work on
unoriented THC/DPPC mixtures [25].
An important objective of this study was to define the
properties governing the interactions between cannabinoids and
the lipid bilayer in order to better delineate the pharmacophore
necessary for ligand efficacy. As postulated by other groups,
THC and CP-55,940 have phenolic hydroxyl groups that may
orient the ligands towards the carboxyl group of the fatty acyl
ester of the membrane due to hydrogen bonding with the
carboxy group of the fatty acids, as is the case for cholesterol
[45]. Whereas the order parameter data indicated the overall
motional ordering of the acyl chains, the 2H NMR data could
not distinguish slight differences in the order parameter between
the sn-1 and sn-2 acyl chains of the DMPC phospholipid.
However, the order parameter profiles and the 2H T1Z relaxation
rates of THC and WIN-55,212-2 demonstrate disorder in the
aligned bicelles (Fig. 3C and D and Fig. 6C and D,
respectively). These results are in contrast to those of previous
studies conducted with 10 mol% cholesterol [46]. Two mol%
concentrations of either THC or WIN-55,212-2 caused a
disordering effect from the upper chain to the end of the acyl
chain of the phospholipid bilayers. Previous studies have
indicated that the THC incorporated into DPPC model
membranes is oriented such that the hydroxyl group is parallel
with the upper chain and the tricyclic ring is perpendicular to the
bilayer normal [47]. This proposed “awkward” orientation is
opposite to that of cholesterol, which prefers its long molecular
axis to be oriented parallel to the bilayer normal. Regardless, theenhanced resolution from the magnetically aligned bicelles
allows us to better discern how THC interacts with the
membrane. Our results indicate that THC reduced the ordering
and altered the fluidity within the lipid bilayer of DMPC model
membranes and is not anchored, or is anchored weakly, at the
carboxyl group of the fatty acyl ester.
The hydrogen bonding interaction is expected to be much
stronger with CP-55,940 as this compound has three hydroxyl
groups compared to the one hydroxyl group in THC. This
proposed interaction is clearly supported by the 2H order
parameter profiles in our study, which demonstrate the unusual
properties of CP-55,940. There is high order at the upper chain,
which could be attributed to a strong H-bonding between the
three hydroxyl groups of CP-55,940 and the carboxyl group of
the fatty acyl ester. The hydrophobic portion of the membrane is
particularly sensitive to disordering, even by drugs that
presumably reside near the surface, as previously demonstrated
by Siarheyeva and coworkers in their 1H NOESY MAS NMR
studies [48]. Therefore, we propose that the unusual properties
of CP-55,940 are a result of the compound taking on an
orientation in which the hydroxyl groups anchor at the carboxyl
group of the fatty acyl ester of the phospholipid, thereby
increasing order and decreasing fluidity at the polar surface,
while simultaneously disrupting the interior of the membrane
along the acyl chain. Previous studies have also shown that
anandamide assumes an extended conformation that spans the
entire bilayer thickness [27]. Our results, which show an
increasing disorder along the length of the acyl chain in bicelles
containing methanandamide, support the notion that ananda-
mide orients in such a fashion.
An important finding in this study is that the influence of the
ligands depends upon the composition of the model mem-
branes. The majority of studies examining the interaction of
cannabinoids with model lipid membranes have been conducted
using zwitterionic phospholipids. However, in vivo cellular
membranes are very heterogeneous, consisting of zwitterionic
and charged phospholipids. Drugs with net charge act quite
differently in charged versus zwitterionic phospholipids and
may have differential actions on the two sides of the bilayer
because of the asymmetry of the phospholipid distribution
[37,48]. To address this discrepancy, we have determined the
biophysical properties of CP-55,940 in a variety of zwitterionic
and charged lipids using DMPC-d54 as the NMR probe. The
bicelles tested were BicPE (a zwitterionic bicelle), as well as
BicPG and BicPS (negatively charged bicelles). The molar ratio
of the DMPC/charged lipid was 9:1. The results indicated that
4 mol% CP-55,940 stabilized the carboxyl group of the fatty
acyl ester of the zwitterionic BicPC and BicPE but had no effect
on the charged BicPG and BicPS bicelles (Fig. 4). Most likely,
the intercalation of CP-55,940 into the membrane of the charged
bicelles causes a change in the dipole of the carboxyl group of
the fatty acyl ester which is dependent on the sign and size of the
surface charge of the bicelles. The change in the dipole in
BicPG and BicPS bicelles can result in a weakening of the
hydrogen bond between the upper chain of the phospholipids
and the ligand. In this case, CP-55,940 does not anchor at the
carboxyl group of the fatty acyl ester as seen with BicPC, but is
2058 E.K. Tiburu et al. / Biochimica et Biophysica Acta 1768 (2007) 2049–2059more deeply intercalated into the membrane in a manner similar
to WIN-55,212-2 and THC. Similar observations involving
other drugs were observed by Siarheyeva and coworkers by 1H
NOESY MAS NMR [48]. These results illustrate the impor-
tance of examining a variety of lipid compositions when
studying the interaction of cannabinoids with lipid bilayers.
To determine how a cannabinoid antagonist interacts with
the lipid bilayer, the 2H order parameters of AM281 were
calculated at 35 °C. The exact concentration of AM281 within
the membrane could not be determined as the ligand was
precipitated out of solution at physiological temperatures
during the analysis. However, it was apparent that AM281
does interact with the lipid bilayer at lower temperatures, as
indicated by its ability to affect the 2H NMR spectra. There are
three possible explanations for AM281's action in our system:
(1) exceptionally low concentrations of AM281 within the lipid
bilayer are required to carry out its activity; (2) AM281 does
not incorporate into zwitterionic phospholipids and thereby
requires a positively or negatively charged bilayer environment
to facilitate its intercalation into the membrane; or (3) the
activity of AM281 is mediated by a receptor binding site not
accessible through the lipid bilayer. The mere fact that the
phase transition temperature changes in the presence of the
antagonist supports the notion that AM281 does accumulate in
the lipid bilayer.
To probe the rate of motion of the acyl chains, we determined
the 2H R1Z measurements (Fig. 6). The molecular motions were
in the fast exchange limit for 2H NMR (i.e.N108 s−1). Our R1Z
results are consistent with the trends shown in the order
parameter profiles in Fig. 3. Membrane fluidity was decreased
at the upper chain in the presence of methanandamide or CP-
55,940, with a corresponding increase in fluidity at the acyl
chains. Thus, methanandamide and CP-55,940 demonstrated
unusual properties in fluidity similar to those seen with the 2H
order parameters in Fig. 3. In the presence of THC or WIN-
55,212-2, the R1Z measurements confirmed that the membrane
fluidity was increased when either ligand was incorporated into
the bicelles. On the contrary, 2 mol% AM281 caused a decrease
in membrane fluidity (Fig. 5B).
Bilayer fluidity is an important determinant of biomembrane
stability as shown in Fig. 7. The fact that the R1Z versus |SCD|
2
graphs display linear plots demonstrates that there is a
functional dependence of the relaxation rates on the motional
amplitudes as described in the order parameter, SCD. We would
have expected a nonlinear plot for a system whose relaxation
rates are independent of the motional amplitudes. Furthermore,
the steeper the slope, the more fluid the bilayer becomes. Thus,
THC and WIN showed a more significant influence on
membrane fluidity than Meth and CP.
Our study indicates that the prototypical cannabinoids
display one of three biophysical profiles. Some ligands such
as THC and WIN-55,212-2 increase the membrane fluidity and
move rapidly throughout the entire lipid bilayer. Other ligands
such as CP-55,940 and methanandamide anchor at the carboxyl
group of the fatty acyl ester and disrupt the acyl chains, while
the antagonist AM281 stabilizes the entire lipid bilayer.
Furthermore, some interactions are mediated by differentmembrane environments as in the case of the zwitterionic and
charged membranes. Our results strongly suggest that canna-
binoid action on the membrane depends upon membrane
composition as well as the structure of the cannabinoid ligands.
These studies should open up new avenues to explore the
mechanism of cannabinoid action on membranes and may
provide insights into the different biological effects induced by
cannabinoid ligands in vivo and in vitro.
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